Navigation Links
NightHawk Radiology exclusive radiology provider for high-risk plaque research initiative

COEUR DALENE, Idaho, January 30, 2008 Preventative heart healthcare gains strong momentum today as NightHawk Radiology Holdings, Inc. (Nasdaq: NHWK), announced its involvement as the exclusive radiology provider for the High-Risk Plaque Initiative (HRP Initiative). The HRP Initiative is a joint research effort to advance the understanding and management of high-risk plaque, which is believed to be the primary underlying cause of heart attacks and strokes.

As part of the research effort, NightHawks U.S. Board Certified radiologists will interpret Chest CT scans for approximately 6,000 study participants. Additionally, NightHawk Radiology Services expects its affiliated radiologists will read approximately 1,000 Cardiac CTA scans performed on a subset of participants believed to be at higher risk for a cardiac event. Cardiac CTA is a heart-imaging test that is rapidly gaining acceptance for its ability to non-invasively determine whether fatty or calcium deposits (i.e., plaque) have built up in the coronary arteries. The purpose of the interpretation of the CT Chest scans by NightHawks affiliated radiologists is to identify clinically significant cardiac and non-cardiac findings where the participant might benefit from its detection and follow-up.

Since there are currently no non-invasive methods of screening, diagnosis, or treatment for high-risk plaque, the HRP Initiatives goal is to provide a roadmap for the development of screening, diagnostic, and therapeutic interventions for high-risk plaque, and promote proper use to patients, providers and payors.

NightHawk was chosen because it was the single teleradiology provider with the strategic experience managing the complex technical aspects and reporting requirements of CCTA reconstructions, said Cherrill Farnsworth, President and Chief Executive Officer of HealthHelp, a radiology benefit management company that is coordinating the teleradiology aspect of the HRP Initiative. NightHawks resources, flexibility, and expertise place them at the forefront of CCTA and the 3D reconstruction. They are the only global provider with a viable solution that is available today.

NightHawk Radiology Services has deployed an independent imaging network solution explicitly for the HRP Initiative and it expects to begin evaluating reads in the first quarter of 2008.

We are very excited to be a part of this initiative, which involves high-profile medical institutions, leading pharmaceutical and medical technology companies, and scientists in the fields of cardiology, pathology, and imaging, said Dr. Paul Berger, Chairman and Chief Executive Officer of NightHawk Radiology Services. Participating in this initiative builds on the opportunities that lie ahead for our new service offerings such as CCTA, which we believe will continue to gain acceptance as the standard non-invasive diagnostic tool.


Contact: Robert Minicucci
Warner Communications

Related medicine news :

1. NightHawk Radiology Holdings, Inc. Announces Date for Third Quarter Earnings Conference Call
2. NightHawk Radiology Holdings, Inc. Releases Record Third Quarter 2007 Results
3. NightHawk Radiology Holdings, Inc. to Speak at Annual Piper Jaffray Healthcare Conference on November 28, 2007
4. NightHawk Radiology: One Source, One Solution
5. NightHawk Radiology Holdings, Inc. to Speak at Annual JPMorgan Healthcare Conference on January 10, 2008
6. NightHawk Radiology Holdings, Inc. Announces Preliminary 2007 Results
7. NightHawk Radiology Holdings, Inc. Announces Date for Fourth Quarter and Full-Year 2007 Earnings Conference Call
8. AIUM CEO named among most influential in radiology
9. Abaxis Announces New Waived Kidney Check Panel Exclusively for Imaging and Radiology Centers
10. Franklin & Seidelmann Enters Full-Service Teleradiology Market with Acquisition of Apex Radiology
11. Radiology Ltd. Chooses AMICAS as End-to-End Solutions Provider
Post Your Comments:
(Date:6/24/2016)... ... , ... Those who have experienced traumatic events may suffer from a complex ... as drug or alcohol abuse, as a coping mechanism. To avoid this pain and ... a traumatic event. , Trauma sufferers tend to feel a range of emotions, from ...
(Date:6/24/2016)... CA (PRWEB) , ... June 24, 2016 , ... Marcy was in a crisis. Her ... would lash out at his family verbally and physically. , “When something upset him, he ... he would use it. He would throw rocks at my other children and say he ...
(Date:6/24/2016)... Fla. (PRWEB) , ... June 24, 2016 , ... Global ... Trend magazine’s 2016 Legal Elite. The attorneys chosen by their peers for this recognition ... Florida. , Seven Greenberg Traurig Shareholders received special honors as members of this year’s ...
(Date:6/24/2016)... ... , ... Comfort Keepers® of San Diego, CA is excited to announce they ... to drive cancer patients to and from their cancer treatments. Comfort Keepers provides ... life and ongoing independence. Getting to and from medical treatments is one of ...
(Date:6/24/2016)... ... June 24, 2016 , ... People across the U.S. are ... Code Talker Award, an essay contest in which patients and their families pay tribute ... presented at the 2016 National Society of Genetic Counselors (NSGC) Annual Education Conference (AEC) ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... June 24, 2016  Arkis BioSciences, a leading ... and more durable cerebrospinal fluid treatments, today announced ... Series-A funding is led by Innova Memphis, followed ... other private investors.  Arkis, new financing will accelerate ... the market release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... , June 23, 2016 Any dentist who ... challenges of the current process. Many of them do not ... the technical difficulties and high laboratory costs involved. And those ... offer it at such a high cost that the majority ... Dr. Parsa Zadeh , founder of Dental ...
(Date:6/23/2016)... Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that it ... (procalcitonin) assay as a dedicated testing solution for people ... Roche is the first IVD company in the U.S ... assessment and management. PCT is a sepsis-specific ... blood can aid clinicians in assessing the risk of ...
Breaking Medicine Technology: